Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a ...
The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback